You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

Home
Topics
Times are shown in your local time zone (GMT )

Future Clinical Uses of OCT for Neurodegenerative Diseases

Description
WAVE On Demand Day2-Bui: OCT Neurodegenerative Diseases

WAVE On Demand Notification -
Please click here to notify us you are watching this On Demand. 
This will ensure your CPD is uploaded quickly.
Certificate Notifications will be sent at the time of CPD verification by the OWA Office.

If you are watching this for the first time and intend to claim the CPD time of 0.5hrs - expect your CPD to be uploaded within 14 days of viewing.
Non members will also be contacted within this timeframe.

If you are watching to recap as you have already seen this presentation at WAVE Live, you are very welcome to watch any WAVE Live presentation but will not be eligible for any CPD.

Summary: Increasingly, neuronal changes and pathology causing proteins that herald a number of central nervous system diseases are also being found in the eye. The ease with which the retina can be accessibility with non-invasive imaging makes it a potentially useful location to screen for neurodegenerative diseases. The prospect that specific signs of common conditions such as Alzheimer’s disease and Parkinson’s disease can be detected using optical coherence tomography is an exciting avenue of clinical application. This talk will summarise the latest developments in this area. 
  
Learning Objective: To better understand the retinal manifestations of common neurodegenerative diseases and how this might manifest in changes the retina detectable using optical coherence tomography.

Assessment:  There are no MCQS for this lecture.

Resources

Summary: Increasingly, neuronal changes and pathology causing proteins that herald a number of central nervous system diseases are also being found in the eye. The ease with which the retina can be accessibility with non-invasive imaging makes it a potentially useful location to screen for neurodegenerative diseases. The prospect that specific signs of common conditions such as Alzheimer’s disease and Parkinson’s disease can be detected using optical coherence tomography is an exciting avenue of clinical application. This talk will summarise the latest developments in this area.
Other Suggested Sessions On Demands

The GDPR does not specifically apply to Optometry Australia / Optometry WA as the latter does not have an establishment in the EU nor intentionally engage in targeted marketing to EU individuals specifically. In relation to the management of member data Optometry Australia's current Privacy Act is fully compliant with the respective GDPR data regulations.

We use cookies to ensure you get the best experience on our platform and by continuing to use this site you agree that we can save them on your device. For more information, please read our privacy policy. Privacy Policy